Publications 2008

Publications 2008

Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene. 27: 421-33, 2008.

Bahar MW, Kenyon JC, Putz MM, Abrescia NG, Pease JE, Wise EL, Stuart DI, Smith GL, Grimes JM.
Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog. 2008 4:e5.

Bailey D, Thackray LB, Goodfellow IG. A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo. J Virol. 82: 7725-8, 2008.

Bhella D, Gatherer D, Chaudhry Y, Pink R, Goodfellow IG. Structural insights into Calicivirus attachment and uncoating. J Virol. 82: 8051-8, 2008.

Chen RA, Ryzhakov G, Cooray S, Randow F, Smith GL. Inhibition of IkappaB Kinase by Vaccinia Virus Virulence Factor B14. PLoS Pathog. 2008 4:e22

Fahy AS, Clark RH, Glyde EF, Smith GL. Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J Gen Virol. 89: 2377-87, 2008.

Graham SC, Bahar MW, Cooray S, Chen RA, Whalen DM, Abrescia NG, Alderton D, Owens RJ, Stuart DI, Smith GL, Grimes JM. Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog. 2008 4: e1000128.

Guzman E, Taylor G, Charleston B, Skinner MA, Ellis SA. An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J Gen Virol. 89: 667-75, 2008.

Hale BG, Barclay WS, Randall RE, Russell RJ. Structure of an avian influenza A virus NS1 protein effector domain. Virology 378: 1-5, 2008

Jacobs N, Bartlett NW, Clark RH, Smith GL.Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection. J Gen Virol. 89: 2877-81, 2008.

Lee LY, Ha DL, Simmons C, de Jong MD, Chau NV, Schumacher R, Peng YC, McMichael AJ, Farrar JJ, Smith GL, Townsend AR, Askonas BA, Rowland-Jones S, Dong T. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest. 118: 3478-90, 2008

Lucchesi W, Brady G, Dittrich-Breiholz O, Kracht M, Russ R and Farrell PJ. Differential gene regulation by Epstein-Barr virus Type 1 and Type 2 EBNA2. Journal of Virology 82: 7456-7466, 2008.

Midgley CM, Putz MM, Weber JN, Smith GL. Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax. J Gen Virol. 89: 2992-7, 2008.

Pathak HB, Oh HS, Goodfellow IG, Arnold JJ, Cameron CE. Picornavirus genome replication: Roles of precursor proteins and rate-limiting steps in oriI-dependent VPg uridylylation. J Biol Chem. 283: 30677-88, 2008.

Roberts KL, Smith GL. Vaccinia virus morphogenesis and dissemination. Trends Microbiol. 16: 472-479, 2008

Simmonds P, Karakasiliotis I, Bailey D, Chaudhry Y, Evans DJ, Goodfellow IG. Bioinformatic and functional analysis of RNA secondary structure elements among different genera of human and animal caliciviruses. Nucleic Acids Res. 36: 2530-46, 2008.

Thorley-Lawson DA and Allday MJ. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol. 12: 913-24, 2008.

Williams P, Verhagen J, Elliott G. Characterization of a CRM1-dependent nuclear export signal in the C terminus of herpes simplex virus type 1 tegument protein UL47. J Virol. 82: 10946-52, 2008.

Young P, Anderton E, Paschos K, White R, Allday MJ. Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones. J Gen Virol. 89: 866-77, 2008.